Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Nouér SA[au]:

Fusariosis. Nucci F et al. Semin Respir Crit Care Med. (2015)

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by <i>Enterobacteriales</i> Coresistant to Carbapenems and Polymyxins. Guimarães T et al. Antimicrob Agents Chemother. (2019)

Time of catheter removal in candidemia and mortality. Nucci M et al. Braz J Infect Dis. (2018)

Search results

Items: 1 to 50 of 53

1.

High rate of neonates colonized by methicillin-resistant Staphylococcus species in an Intensive Care Unit.

Salgueiro VC, Seixas MDL, Guimarães LC, Ferreira DC, Da Cunha DC, Nouér SA, Dos Santos KRN.

J Infect Dev Ctries. 2019 Sep 30;13(9):810-816. doi: 10.3855/jidc.11241.

2.

Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.

da Costa TM, Cuba GT, Morgado PGM, Nicolau DP, Nouér SA, Dos Santos KRN, Kiffer CRV.

BMC Infect Dis. 2020 Jan 23;20(1):74. doi: 10.1186/s12879-020-4782-9.

3.

Shock and Early Death in Hematologic Patients with Febrile Neutropenia.

Guarana M, Nucci M, Nouér SA.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e01250-19. doi: 10.1128/AAC.01250-19. Print 2019 Nov.

PMID:
31405857
4.

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Enterobacteriales Coresistant to Carbapenems and Polymyxins.

Guimarães T, Nouér SA, Martins RCR, Perdigão Neto LV, Martins WMBS, Narciso Barbosa AC, Ferreira ALP, Costa SF, Gales AC.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00528-19. doi: 10.1128/AAC.00528-19. Print 2019 Oct.

5.

Daptomycin and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus clonal lineages from bloodstream infection in a Brazilian teaching hospital.

Damasco AP, Costa TMD, Morgado PGM, Guimarães LC, Cavalcante FS, Nouér SA, Santos KRND.

Braz J Infect Dis. 2019 Mar - Apr;23(2):139-142. doi: 10.1016/j.bjid.2019.03.003. Epub 2019 Apr 24.

6.

Performance of 1,3-beta-D-glucan in the diagnosis and monitoring of invasive fusariosis.

Nucci M, Barreiros G, Reis H, Paixão M, Akiti T, Nouér SA.

Mycoses. 2019 Jul;62(7):570-575. doi: 10.1111/myc.12918. Epub 2019 May 14.

PMID:
31025423
7.

Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?

Nucci M, Shoham S, Abdala E, Hamerschlak N, Rico JC, Forghieri F, Nouér SA, Cappellano P, Solza C, Gonzaga Y, Nadali G, Nucci F, Colombo AL, Albuquerque AM, Queiroz-Telles Filho F, Lima CBL, Arrais-Rodrigues C, Rocha V, Marty FM.

Mycoses. 2019 May;62(5):413-417. doi: 10.1111/myc.12901.

PMID:
30720902
8.

Time of catheter removal in candidemia and mortality.

Nucci M, Braga PR, Nouér SA, Anaissie E.

Braz J Infect Dis. 2018 Nov - Dec;22(6):455-461. doi: 10.1016/j.bjid.2018.10.278. Epub 2018 Nov 20.

9.

Secular trends of candidemia at a Brazilian tertiary care teaching hospital.

Braga PR, Cruz IL, Ortiz I, Barreiros G, Nouér SA, Nucci M.

Braz J Infect Dis. 2018 Jul - Aug;22(4):273-277. doi: 10.1016/j.bjid.2018.07.008. Epub 2018 Aug 16.

10.

Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis.

Nucci F, Nouér SA, Capone D, Nucci M.

Clin Microbiol Infect. 2018 Oct;24(10):1105.e1-1105.e4. doi: 10.1016/j.cmi.2018.05.006. Epub 2018 May 19.

11.

Characteristics of methicillin-resistant Staphylococcus aureus in patients on admission to a teaching hospital in Rio de Janeiro, Brazil.

Cavalcante FS, Pinheiro MV, Ferreira DC, Alvarenga CVDCG, Guimarães ACF, Nouér SA, Dos Santos KRN.

Am J Infect Control. 2017 Nov 1;45(11):1190-1193. doi: 10.1016/j.ajic.2017.06.003. Epub 2017 Jul 24.

PMID:
28751036
12.

Vitek®2 cannot identify vancomycin-intermediate isolates: missing the opportunity for Staphylococcus aureus therapy.

Morgado PGM, da Costa TM, Damasco AP, Ribeiro VN, Ferreira ALP, Nouér SA, Santos KRND.

J Hosp Infect. 2018 Feb;98(2):170-172. doi: 10.1016/j.jhin.2017.07.014. Epub 2017 Jul 19. No abstract available.

PMID:
28734724
13.

Complete substitution of the Brazilian endemic clone by other methicillin-resistant Staphylococcus aureus lineages in two public hospitals in Rio de Janeiro, Brazil.

Chamon RC, Ribeiro SD, da Costa TM, Nouér SA, Dos Santos KR.

Braz J Infect Dis. 2017 Mar - Apr;21(2):185-189. doi: 10.1016/j.bjid.2016.09.015. Epub 2016 Nov 19.

14.

Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.

Varon AG, Nouér SA, Barreiros G, Trope BM, Akiti T, Nucci M.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7290-7294. Print 2016 Dec.

15.

Mechanisms of carbapenem resistance in endemic Pseudomonas aeruginosa isolates after an SPM-1 metallo-β-lactamase producing strain subsided in an intensive care unit of a teaching hospital in Brazil.

Cacci LC, Chuster SG, Martins N, Carmo PR, Girão VB, Nouér SA, Freitas WV, Matos JA, Magalhães AC, Ferreira AL, Picão RC, Moreira BM.

Mem Inst Oswaldo Cruz. 2016 Sep;111(9):551-8. doi: 10.1590/0074-02760160116.

16.

Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.

da Costa TM, Morgado PG, Cavalcante FS, Damasco AP, Nouér SA, Dos Santos KR.

PLoS One. 2016 Aug 30;11(8):e0160506. doi: 10.1371/journal.pone.0160506. eCollection 2016.

17.

Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.

Nucci M, Nouér SA, Esteves P, Guimarães T, Breda G, de Miranda BG, Queiroz-Telles F, Colombo AL.

J Antimicrob Chemother. 2016 Sep;71(9):2628-33. doi: 10.1093/jac/dkw188. Epub 2016 Jun 10.

PMID:
27287231
18.

Invasive fungal diseases in patients with acute lymphoid leukemia.

Nicolato A, Nouér SA, Garnica M, Portugal R, Maiolino A, Nucci M.

Leuk Lymphoma. 2016 Sep;57(9):2084-9. doi: 10.3109/10428194.2016.1154957. Epub 2016 Mar 7.

PMID:
26949001
19.

Effect of the implosion and demolition of a hospital building on the concentration of fungi in the air.

Barreiros G, Akiti T, Magalhães AC, Nouér SA, Nucci M.

Mycoses. 2015 Dec;58(12):707-13. doi: 10.1111/myc.12418. Epub 2015 Oct 8.

PMID:
26449634
20.

Fusariosis.

Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M.

Semin Respir Crit Care Med. 2015 Oct;36(5):706-14. doi: 10.1055/s-0035-1562897. Epub 2015 Sep 23. Review.

PMID:
26398537
21.

Distinguishing the Causes of Pulmonary Infiltrates in Patients With Acute Leukemia.

Nucci M, Nouér SA, Anaissie E.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S98-103. doi: 10.1016/j.clml.2015.03.007.

PMID:
26297289
22.

Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.

Nouér SA, Nucci M, Anaissie E.

Expert Rev Hematol. 2015 Oct;8(5):647-58. doi: 10.1586/17474086.2015.1060576. Epub 2015 Jun 26. Review.

PMID:
26115679
23.

Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.

Colombo AL, Guimarães T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, Nouér SA, Nucci M.

Intensive Care Med. 2014 Oct;40(10):1489-98. doi: 10.1007/s00134-014-3400-y. Epub 2014 Aug 1. Erratum in: Intensive Care Med. 2014 Dec;40(12):1974.

24.

Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.

Secco DA, Balassiano IT, Boente RF, Miranda KR, Brazier J, Hall V, dos Santos-Filho J, Lobo LA, Nouér SA, Domingues RM.

Anaerobe. 2014 Aug;28:85-9. doi: 10.1016/j.anaerobe.2014.05.013. Epub 2014 Jun 5.

PMID:
24907488
25.

Vancomycin minimum inhibitory concentrations using different susceptibility methods in Staphylococcus aureus isolates.

Sousa AG, da Costa TM, Cavalcante FS, Chamon RC, Ferreira DC, Nouér SA, dos Santos KR.

J Infect Dev Ctries. 2014 Apr 15;8(4):558-60. doi: 10.3855/jidc.4395. No abstract available.

26.

Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing.

Nucci M, Carlesse F, Cappellano P, Varon AG, Seber A, Garnica M, Nouér SA, Colombo AL.

PLoS One. 2014 Jan 28;9(1):e87784. doi: 10.1371/journal.pone.0087784. eCollection 2014.

27.

Meticillin-resistant Staphylococcus aureus: spread of specific lineages among patients in different wards at a Brazilian teaching hospital.

Cavalcante FS, Schuenck RP, Ferreira DC, da Costa CR, Nouér SA, dos Santos KR.

J Hosp Infect. 2014 Feb;86(2):151-4. doi: 10.1016/j.jhin.2013.12.004. Epub 2013 Dec 21.

PMID:
24433925
28.

Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome.

Nucci M, Nouér SA, Cappone D, Anaissie E.

Haematologica. 2013 Nov;98(11):1657-60. doi: 10.3324/haematol.2013.094359. No abstract available.

29.

Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil.

Nucci M, Varon AG, Garnica M, Akiti T, Barreiros G, Trope BM, Nouér SA.

Emerg Infect Dis. 2013 Oct;19(10):1567-72. doi: 10.3201/eid1910.120847.

30.

Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis.

Varon AG, Nouer SA, Barreiros G, Trope BM, Magalhães F, Akiti T, Garnica M, Nucci M.

J Infect. 2014 Jan;68(1):85-9. doi: 10.1016/j.jinf.2013.08.011. Epub 2013 Aug 28.

PMID:
23994063
31.

Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.

Garnica M, Nouér SA, Pellegrino FL, Moreira BM, Maiolino A, Nucci M.

BMC Infect Dis. 2013 Jul 31;13:356. doi: 10.1186/1471-2334-13-356.

32.

Dissemination of Acinetobacter nosocomialis clone among critically ill patients and the environment.

de Carvalho Girão VB, Martins N, Cacci LC, Coelho-Souza T, Nouér SA, Riley LW, Moreira BM.

J Clin Microbiol. 2013 Aug;51(8):2707-9. doi: 10.1128/JCM.00915-13. Epub 2013 May 22.

33.

Tetracycline and trimethoprim/sulfamethoxazole at clinical laboratory: can they help to characterize Staphylococcus aureus carrying different SCCmec types?

Cavalcante FS, Schuenck RP, Caboclo RM, Ferreira Dde C, Nouér SA, Santos KR.

Rev Soc Bras Med Trop. 2013 Jan-Feb;46(1):100-2.

34.

Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.

Martins N, Martins IS, de Freitas WV, de Matos JA, Girão VB, Coelho-Souza T, Maralhães AC, Cacci LC, de Figueiredo MP, Dias RC, Costa-Lourenço AP, Ferreira AL, Dalla-Costa L, Nouér SA, Santoro-Lopes G, Riley LW, Moreira BM.

Microb Drug Resist. 2013 Jun;19(3):216-23. doi: 10.1089/mdr.2012.0174. Epub 2013 Jan 21.

PMID:
23336529
35.

Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.

Nouér SA, Nucci M, Kumar NS, Grazziutti M, Restrepo A, Anaissie E.

Clin Infect Dis. 2012 Jun;54(12):e173-83. doi: 10.1093/cid/cis298. Epub 2012 Mar 15.

36.

Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii.

Martins N, Martins IS, de Freitas WV, de Matos JA, Magalhães AC, Girão VB, Dias RC, de Souza TC, Pellegrino FL, Costa LD, Boasquevisque CH, Nouér SA, Riley LW, Santoro-Lopes G, Moreira BM.

Transpl Infect Dis. 2012 Jun;14(3):316-20. doi: 10.1111/j.1399-3062.2011.00701.x. Epub 2011 Dec 14.

37.

Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition.

Nouér SA, Nucci M, Kumar NS, Grazziutti M, Barlogie B, Anaissie E.

Clin Infect Dis. 2011 Oct;53(7):671-6. doi: 10.1093/cid/cir441. Epub 2011 Aug 16.

38.

Methicillin-resistant Staphylococcus lugdunensis carrying SCCmec type V misidentified as MRSA.

Pereira EM, Schuenck RP, Nouér SA, Santos KR.

Braz J Infect Dis. 2011 May-Jun;15(3):293-5.

39.

Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies.

Nucci M, Nouér SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E.

Clin Infect Dis. 2010 Dec 1;51(11):1273-80. doi: 10.1086/657065. Epub 2010 Oct 29.

PMID:
21034199
40.

Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.

Balassiano IT, dos Santos-Filho J, Vital-Brazil JM, Nouér SA, Souza CR, Brazier JS, Ferreira Ede O, Domingues RM.

Antonie Van Leeuwenhoek. 2011 Feb;99(2):249-55. doi: 10.1007/s10482-010-9483-8. Epub 2010 Jul 11.

PMID:
20623188
41.

A cluster of Listeria monocytogenes infections in hospitalized adults.

Martins IS, Faria FC, Miguel MA, Dias MP, Cardoso FL, Magalhães AC, Mascarenhas LA, Nouér SA, Barbosa AV, Vallim DC, Hofer E, Rabello RF, Riley LW, Moreira BM.

Am J Infect Control. 2010 Nov;38(9):e31-6. doi: 10.1016/j.ajic.2010.02.014. Epub 2010 Jun 8. Erratum in: Am J Infect Control. 2010 Dec;38(10):849. Rebello, Renata Fernandes [corrected to Rabello, Renata Fernandes].

42.

Case-crossover study of Burkholderia cepacia complex bloodstream infection associated with contaminated intravenous bromopride.

Martins IS, Pellegrino FL, Freitas Ad, Santos Mda S, Ferraiuoli GI, Vasques MR, Amorim EL, Oliveira S, Nouér SA, Cardoso FL, Mascarenhas LA, Magalhães AC, Cleinman IB, Figueiredo AM, Moreira BM.

Infect Control Hosp Epidemiol. 2010 May;31(5):516-21. doi: 10.1086/651667.

PMID:
20205589
43.

Polyclonal presence of non-multiresistant methicillin-resistant Staphylococcus aureus isolates carrying SCCmec IV in health care-associated infections in a hospital in Rio de Janeiro, Brazil.

Schuenck RP, Nouér SA, Winter Cde O, Cavalcante FS, Scotti TD, Ferreira AL, Giambiagi-de Marval M, dos Santos KR.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):434-41. doi: 10.1016/j.diagmicrobio.2009.04.007.

PMID:
19631097
44.

A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.

Pellegrino FL, Casali N, Nouér SA, Riley LW, Moreira BM.

Diagn Microbiol Infect Dis. 2008 Jun;61(2):214-6. doi: 10.1016/j.diagmicrobio.2008.01.005. Epub 2008 Mar 4.

PMID:
18308497
45.

Improved and rapid detection of methicillin-resistant Staphylococcus aureus nasal carriage using selective broth and multiplex PCR.

Schuenck RP, Lourenco MC, Iório NL, Ferreira AL, Nouér SA, Santos KR.

Res Microbiol. 2006 Dec;157(10):971-5. Epub 2006 Sep 12.

PMID:
17005377
46.

Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.

Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J; Brazilian Network Candidemia Study.

J Clin Microbiol. 2006 Aug;44(8):2816-23.

47.

Pseudomonas aeruginosa epidemic strain carrying bla(SPM) metallo-beta-lactamase detected in Rio de Janeiro, Brazil.

Pellegrino FL, Casali N, Dos Santos KR, Nouér SA, Scheidegger EM, Riley LW, Moreira BM.

J Chemother. 2006 Apr;18(2):151-6.

PMID:
16736883
48.

Endemic extended-spectrum beta-lactamase-producing Klebsiella pneumoniae at an intensive care unit: risk factors for colonization and infection.

Martins IS, Pessoa-Silva CL, Nouer SA, Pessoa de Araujo EG, Ferreira AL, Riley LW, Moreira BM.

Microb Drug Resist. 2006 Spring;12(1):50-8.

PMID:
16584309
49.

Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.

Nouér SA, Nucci M, de-Oliveira MP, Pellegrino FL, Moreira BM.

Antimicrob Agents Chemother. 2005 Sep;49(9):3663-7.

50.

Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients.

Nucci M, Nouér SA, Garnica M, de Oliveira AL, Maiolino A.

Bone Marrow Transplant. 2004 May;33(9):973-4; author reply 975-6. No abstract available.

PMID:
15004545

Supplemental Content

Loading ...
Support Center